ReviewJournal of pain research2026
Targeting Inflammatory Cell Death: A Strategy for Discogenic Pain Relief.
Review in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Microtubule Cytoskeleton Dysfunction in Chronic Pain: Mechanisms of Transport Failure and Emerging Therapeutic Targets.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Low back pain caused by intervertebral disc degeneration (IVDD) remains a major challenge in clinical management, and its underlying mechanisms have not yet been fully elucidated. Beyond apoptosis, recent studies have shown that pyroptosis, ferroptosis, and necroptosis-as key inflammatory programmed cell death pathways-actively contribute to the pathological progression of IVDD and the development of pain. Currently, effective clinical solutions for discogenic pain are still lacking. This review systematically elaborates on the mechanisms of pyroptosis, ferroptosis, and necroptosis, and explains their activation in different anatomical regions of the intervertebral disc (nucleus pulposus, annulus fibrosus, and endplate). These processes promote pain by altering the local microenvironment, such as through the release of inflammatory factors and the disruption of tissue structure. Furthermore, the article summarizes potential therapeutic strategies targeting these specific cell death pathways, including molecular inhibitors, natural compounds (eg, hesperidin, melatonin), and traditional formulations, with a focus on their prospects for alleviating IVDD-related pain by modulating core cell death mechanisms. By systematically reviewing these novel cell death mechanisms and related therapeutic strategies, this work aims to provide new insights and evidence for the clinical management of discogenic pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.